Spinal Cord Stimulators (SCS) Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update
Spinal Cord Stimulators (SCS) Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update
Summary
GlobalData's Medical Devices sector report, “Spinal Cord Stimulators (SCS) Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update provides comprehensive information about the Spinal Cord Stimulators (SCS) pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
An Spinal Cord Stimulators (SCS) is a device that comprises a surgically implanted electrical pacemaker and electrodes that connect to the spinal cord to treat chronic pain disorders.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
Extensive coverage of the Spinal Cord Stimulators (SCS) under development
The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
The report reviews the major players involved in the development of Spinal Cord Stimulators (SCS) and list all their pipeline projects
The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
The report provides key clinical trial data of ongoing trials specific to pipeline products
Recent developments in the segment / industry
Reasons to Buy
The report enables you to -
Formulate significant competitor information, analysis, and insights to improve R&D strategies
Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
Identify and understand important and diverse types of Spinal Cord Stimulators (SCS) under development
Develop market-entry and market expansion strategies
Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
In-depth analysis of the product’s current stage of development, territory and estimated launch date
Introduction
Spinal Cord Stimulators (SCS) Overview
Products under Development
Spinal Cord Stimulators (SCS) - Pipeline Products by Stage of Development
Table Spinal Cord Stimulators (SCS) - Pipeline Products by Stage of Development
Table Spinal Cord Stimulators (SCS) - Pipeline Products by Stage of Development
Spinal Cord Stimulators (SCS) - Pipeline Products by Segment
Table Spinal Cord Stimulators (SCS) - Pipeline Products by Segment
Table Spinal Cord Stimulators (SCS) - Pipeline Products by Segment
Spinal Cord Stimulators (SCS) - Pipeline Products by Territory
Table Spinal Cord Stimulators (SCS) - Pipeline Products by Territory
Table Spinal Cord Stimulators (SCS) - Pipeline Products by Territory
Spinal Cord Stimulators (SCS) - Pipeline Products by Regulatory Path
Table Biostim-5 Transcutaneous Spinal Stimulator - Neuromodulation of Blood Pressure Using Transcutaneous Spinal Stimulation in Chronic Spinal Cord Injury
Table Biostim-5 Transcutaneous Spinal Stimulator - Neuromodulation of Blood Pressure Using Transcutaneous Spinal Stimulation in Individuals With an Acute Spinal Cord Injury - A Safety, Feasibility and Efficacy Study
Table Biostim-5 Transcutaneous Spinal Stimulator - Neuromodulatory Rehabilitation for Respiratory Motor Function in Individuals With Chronic Spinal Cord Injury
Table Biostim-5 Transcutaneous Spinal Stimulator - Non-invasive Spinal Stimulation as an Adjuvant Therapy for Trunk Control after Pediatric Spinal Cord Injury
Direct Spinal Therapeutics, Inc. Company Overview
Direct Spinal Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table Direct Spinal Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table Iowa-Patch System - Product Status
Table Iowa-Patch System - Product Description
Duke University Company Overview
Duke University Pipeline Products & Ongoing Clinical Trials Overview
Table Duke University Pipeline Products & Ongoing Clinical Trials Overview
Table Senza HF10 Therapy System - Painful Diabetic Neuropathy - A Post-market, Multicenter, Prospective, Global Clinical Study to Evaluate the Real-world Experience of Spinal Cord Stimulation That Includes 10 kHz in the Management of Chronic Intractable Pain Associated with Diabetic Neuropathy
Table Senza HF10 Therapy System - Painful Diabetic Neuropathy - PDN-SENSORY: A Multi-Center Randomized Controlled Trial to Evaluate Pain and Neurological Function with 10 kHz SCS in Treatment of Painful Diabetic Neuropathy
Table Senza HF10 Therapy System - Pelvic Pain - A Prospective Clinical Study to Assess the Spinal Cord Stimulation System in the Treatment of Chronic Pelvic Pain
Table Onward Medical NV - Ongoing Clinical Trials Overview
Table ARC-IM BCI - Mobility - Brain Controlled Spinal Cord Stimulation in Participants With Cervical Spinal Cord Injury for Upper Limb Rehabilitation (UP2)
Table ARC-IM BCI - Mobility - Efficacy of Spinal Epidural Electrical Stimulation (EES) in Combination with Robot-assisted Neurorehabilitation in Patients with Spinal Cord Injury (STIMO)
Table ARC-IM BCI - Mobility - Targeting Improvements in Bowel Function and Quality of Life Using Epidural Stimulation and Training After Severe Spinal Cord Injury
Table ARC-EX - Activity Dependent Rehabilitation Via Transcutaneous Electrical Spinal Stimulation to Restore Upper Extremity Functions in Spinal Cord Injury
Table ARC-EX - Transcutaneous Spinal Cord Stimulation to Promote Walking Recovery after Spinal Cord Injury
Table ARC-IM - Blood Pressure And Trunk Control - Epidural Electrical Stimulation to Restore Hemodynamic Stability and Trunk Control in People with Spinal Cord Injury
Table ARC-IM - Parkinson's Disease - Study on Preliminary Safety and Efficacy of the ARC-IM Therapy to Alleviate Locomotor Deficits in People With Parkinson's Disease
Table Evoke Spinal Cord Stimulator System - Product Status
Table Evoke Spinal Cord Stimulator System - Product Description
Table Saluda Medical Pty Ltd - Ongoing Clinical Trials Overview
Table Evoke Spinal Cord Stimulator System - A Feasibility Study Evaluating Saluda Medical's Spinal Cord Stimulation System Incorporating Feedback Control to Treat Patients with Chronic Pain of Upper Limb and/or Neck
Table Evoke Spinal Cord Stimulator System - A prospective Feasibility Study Examining the Ability of Closed-loop Spinal Cord Stimulation to Reduce Lower Limb Spasticity in Children Living with Cerebral Palsy: "The Liberty Trial"
Table Evoke Spinal Cord Stimulator System - A Prospective, Multicenter, Single-arm Study Evaluating the Clinical Utility of Neurophysiological Measurements of ECAP-controlled Closed-loop Spinal Cord Stimulation (SCS) to Guide Treatment of Patients With Chronic Pain of the Trunk and/or Limbs.
Table Evoke Spinal Cord Stimulator System - A Prospective, Multicentre, Single-arm Feasibility Study Examining Novel Treatment Delivery of the Evoke Spinal Cord Stimulator (SCS) System to Treat Patients with Chronic Pain of the Trunk And/or Limbs
Table Evoke Spinal Cord Stimulator System - Assessment of Effectiveness and Stimulation Coverage of Closed-loop Spinal Cord
Table Evoke Spinal Cord Stimulator System - EVOKE ECAP-Controlled Lead Placement and Programming in Chronic Pain Patients
Table Evoke Spinal Cord Stimulator System - Real-World Efficacy of Evoke Closed-loop Spinal Cord Stimulation (CL-SCS) Therapy in Chronic Pain Patients (ULTRA)
Table Evoke Spinal Cord Stimulator System - Targeting the Conus Medullaris With ECAP-Controlled Closed-Loop SCS for the Treatment of Chronic Pelvic Pain: HOPE Trial
Table Soterix Medical Inc - Ongoing Clinical Trials Overview
Table 1×1 tDCS Device - Altering Multitasking Behavior Using Low Current Brain Stimulation
Table 1×1 tDCS Device - Effects of Transcranial Direct Current Stimulation (tDCS) on Motor Function in Schizophrenia Patients and Individuals at Risk for Psychotic Onset
Table 1×1 tDCS Device - Non-invasive Neuromodulation to Enhance Targeted Cognitive Remediation in Older Adults With Depression
Table 1×1 tDCS Device - Phase II Clinical Trial of Transcranial Direct Current Stimulation in the Treatment of Primary Progressive Aphasia
Table 1×1 tDCS Device - Pragmatic Trial of Remote tDCS and Somatosensory Training for Phantom Limb Pain with Machine Learning to Predict Treatment Response
Table 1×1 tDCS Device - SMART Stimulation: Precision Neuromodulation of Cognition in Older Adults
Table 1×1 tDCS Device - Transcranial Direct Current Stimulation for Gait Recovery Following Stroke
Table 1×1 tDCS Device - Using tDCS in Speech-based Stroke Rehabilitation
Table Stimdia Medical Inc - Ongoing Clinical Trials Overview
Table pdSTIM System - Randomized Study of the pdSTIM System (Phrenic Nerve to Diaphragm STIMulation) in Failure to Wean Mechanically Ventilated Patients
Apr 23, 2024: Neuronoff Announces Safety and Functionality Success in First-in-Human Trial of Injectrode for Minimally Invasive Chronic Pain Relief (LIFE study)
Apr 10, 2024: Cigna and EviCore Add Positive Coverage for the Evoke System
Apr 09, 2024: SpineX eyes FDA submission as neurogenic bladder trial hits milestone
Apr 02, 2024: ONWARD Medical Submits De Novo Application to FDA for its ARC-EX System
Mar 22, 2024: VA Stand Act Introduced in the United States Senate
Mar 19, 2024: Canadian First - Abbott Advances Chronic Pain Management with the World's Smallest Implanted, Rechargeable Spinal Cord Stimulation System
Mar 19, 2024: Mainstay Medical Announces Publication of the First Neuromodulation Study for Low Back Pain with 5-Year Follow-Up
Mar 18, 2024: ONWARD's ARC-EX System advances towards commercial launch
Mar 12, 2024: Mainstay Medical Announces Publication of Clinical Results Comparing Older Patients and Younger Patients
Mar 12, 2024: Medtronic To Present At Barclays Global Healthcare Conference
Feb 29, 2024: Onward Medical Awarded 10th Breakthrough Device Designation for Brain-Computer Interface (BCI) From US FDA
Feb 28, 2024: Boston Scientific Raises $2.2B to Support Purchase of California Medical Device Company
Feb 23, 2024: Medical Tech Leader, Boston Scientific (BSX), Announces Notes Offering
Feb 19, 2024: Boston Scientific Appoints Madan Krishnan to Lead India Subcontinent
Feb 13, 2024: Mainstay Medical's ReActiv8 MRI labelling secures FDA approval
Feb 07, 2024: FDA approves Boston Scientific's WaveWriter SCS Systems
Feb 07, 2024: Onward Medical Announces Presentation at Biocapital Europe
Feb 07, 2024: Onward Medical Announces Presentation at Biocapital Europe
Feb 01, 2024: Neuronoff Announces Successful First-in-Human Study of Injectrode Technology for Chronic Pain
Feb 01, 2024: Nevro Announces Consensus Statement Supporting High-Frequency (10 kHz) Spinal Cord Stimulation Therapy for Refractory Painful Diabetic Neuropathy
Jan 31, 2024: Boston Scientific Announces Results for Fourth Quarter and Full Year 2023
Jan 29, 2024: Nevro to Report Fourth-Quarter and Full-Year 2023 Financial Results and Host Conference Call on February 21, 2024
Jan 25, 2024: ONWARD ARC Therapy Highlighted at 2024 Annual Meeting of the North American Neuromodulation Society (NANS)
Jan 23, 2024: Nalu Medical Presents Long-term and Holistic Outcomes from the COMFORT RCT for PNS at NANS 2024
Jan 23, 2024: Nalu Medical Presents Long-Term and Holistic Outcomes From the COMFORT RCT for PNS at NANS 2024
Jan 22, 2024: ONWARD to Participate in Basel Healthtech Conference 2024
Jan 20, 2024: Boston Scientific Presents Key Data at the 2024 North American Neuromodulation Society Meeting
Jan 19, 2024: ONWARD to Participate in Degroof Petercam Healthcare Conference
Jan 18, 2024: ONWARD Announces Start of HemON NL Clinical Study
Jan 18, 2024: Nevro Announces Positive Coverage Update from Carelon Healthcare for the Treatment of Painful Diabetic Neuropathy
Jan 18, 2024: Abbott's Proclaim Drg Neurostimulation System Offers Expanded MRI Access for People Suffering From Chronic Pain
Jan 18, 2024: Revolutionizing Spine Surgery Techniques: Inspan Publishes First L5-S1 Spinal Fixation Research for Degenerative Disc and Stenosis in Premier Spine Surgery Journal
Jan 17, 2024: Nevro to Highlight 25 Scientific Abstracts at 2024 North American Neuromodulation Society (NANS) Annual Meeting
Jan 16, 2024: Saluda Medical Announces Late Breaking Data at NANS 2024 Annual Meeting
Jan 10, 2024: Nevro Laying Off 63 People To Strengthen Financial Position
Jan 05, 2024: Boston Scientific Announces Conference Call Discussing Fourth Quarter 2023 Results
Jan 03, 2024: SpineX Announces Successful in-Human Results to Treat Adults with Cerebral Palsy
Nov 29, 2023: Nalu Medical, Announces Positive Results of US Spinal Cord Stimulation Clinical Study in Pain Physician Journal
Nov 20, 2023: Nevro Delivers Long-Term Relief with High-Frequency Spinal Cord Stimulation: 24-Month Data Demonstrates Profound Improvements for Non-Surgical Refractory Back Pain
Nov 10, 2023: Medtronic Announces 12-Month Study Results Showing DTM Spinal Cord Stimulation Programming Provides Long-Term, Significant Pain Relief for Indicated Chronic Back Pain Patients Not Eligible for Spine Surgery
Nov 09, 2023: SpineX Demonstrates Ground Breaking Technology to Improve Bladder Function in Stroke Survivors
Nov 06, 2023: Nature Medicine Publication Highlights Potential for ONWARD ARC Therapy to Improve Mobility After Parkinson's Disease
Oct 26, 2023: Boston Scientific Announces Results for Third Quarter 2023
Oct 17, 2023: Enrollment Completed in Synerfuse Proof-Of-Concept Study
Oct 11, 2023: Boston Scientific Receives FDA Approval of Spinal Cord Stimulation Therapy for People Living with Diabetic Peripheral Neuropathy
Oct 11, 2023: ONWARD Schedules Webcast to Provide Third Quarter 2023 Business Update
Oct 05, 2023: Newly Published Data Supports Effectiveness of BIOTRONIK Neuro's RESONANCE Stimulation
Oct 04, 2023: Medtronic Names Paolo Di Vincenzo President of the Neuromodulation Business
Oct 04, 2023: Nevro to Report Third Quarter 2023 Financial Results
Oct 03, 2023: Stimdia Medical Initiates FDA Approved IDE Pivotal Trial to Investigate Impact of Neuromuscular Stimulation on Mechanically Ventilated Patients
Sep 27, 2023: ONWARD Announces First-in-Human Implant of ARC-IM Stimulator with Brain-Computer Interface (BCI) to Restore Arm, Hand, and Finger Function after Spinal Cord Injury
Sep 26, 2023: SpineX Receives NIH SBIR Phase II Award for SCiP Clinical Trial in Children With CP
Sep 19, 2023: Onward Medical Reports 2023 Half Year Results and Business Update
Sep 18, 2023: New Data Demonstrate the Health Economic Benefits of Nevro's High-Frequency Spinal Cord Stimulation Therapy
Sep 06, 2023: Mainstay Medical Announces Issuance of Statement from the International Society for the Advancement of Spine Surgery (ISASS) on Restorative Neurostimulation
Sep 05, 2023: ONWARD Schedules Webcast to Provide Half Year 2023 Business Update
Aug 30, 2023: Mainstay Medical Announces Completion of Enrollment of RESTORE Clinical Trial of ReActiv8 in the United States
Aug 28, 2023: Medtronic's spinal cord stimulator receives CE Mark
Aug 26, 2023: Medtronic Q2 2024 Earnings Estimates Increased by William Blair
Aug 16, 2023: New 24-Month Data Shows Nevro's SCS Therapy Provides Highly Effective, Long-Term Relief from Painful Diabetic Neuropathy
Aug 10, 2023: Nevro Announces Launch Of HFX Connect In Europe And CE Marking Of Expanded Labelling For The HFX SCS System
Aug 08, 2023: Medtronic to Announce Financial Results for its First Quarter of Fiscal Year 2024
Aug 07, 2023: Tiny, Flexible Spinal Probe System Could Lead to Better Therapies
Aug 04, 2023: Saluda Medical Announces Publication of Favorable Economic Analysis Demonstrating Cost-Dominance of Evoke(R) Closed-Loop SCS over Open-Loop SCS
Jul 27, 2023: Soin tests TunedTX platform using low-frequency stimulation on humans
Jul 27, 2023: Leading Medtech Company Spinex Releases Groundbreaking Results of New Cerebral Palsy Therapies
Jul 20, 2023: Mainstay Medical Announces Publication of Three-Year Clinical Trial Data from Post-Market Clinical Follow-up Registry of ReActiv8 in the United Kingdom
Jul 20, 2023: Nalu Medical, Presents Important New Clinical Data for PNS and SCS at ASPN 2023
Jul 19, 2023: Boston Scientific lays off 52 workers as it closes another Silicon Valley facility
Jul 13, 2023: Nevro Announces Presentations at American Society of Pain & Neuroscience Fifth Annual Conference
Jul 13, 2023: Medtronic Shares Impact of Medicare Coverage Updates That Now Allow Nationwide Access to Spinal Cord Stimulation Therapy for the Treatment of Painful Diabetic Peripheral Neuropathy